Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zernig

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Der Nervenarzt|December 19, 2013
[Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]G Gründer, P Baumann, A Conca, et al.
Psychopharmacology|June 27, 2000
In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in ratsW Koek, M B Assié, G Zernig, et al.
Chirality|January 1, 1993
Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studiesK Stoschitzky, G Egginger, G Zernig, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assaysG Zernig, T Burke, J W Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Butorphanol: characterization of agonist and antagonist effects in rhesus monkeysE R Butelman, G Winger, G Zernig, et al.
Arzneimittel-Forschung|January 1, 1985
Calcium channels and calcium channel drugs: recent biochemical and biophysical findingsH Glossmann, D R Ferry, A Goll, et al.
Neuroscience Applied|July 14, 2025
Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysisF Amann, M Kochtyrew, G Zernig, et al.
The American Journal of Cardiology|November 7, 1989
Hydrophobic calcium channel ligands: methodical problems and their solutionI Graziadei, G Zernig, A Grassegger, et al.
Pharmacology|March 28, 2003
Intravenous drug injection habits: drug users' self-reports versus researchers' perceptionG Zernig, S Giacomuzzi, Y Riemer, et al.
Molecular Pharmacology|September 1, 1990
Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channelG Zernig, I Graziadei, T Moshammer, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Der Nervenarzt|December 19, 2013
[Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]G Gründer, P Baumann, A Conca, et al.
Psychopharmacology|June 27, 2000
In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in ratsW Koek, M B Assié, G Zernig, et al.
Chirality|January 1, 1993
Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studiesK Stoschitzky, G Egginger, G Zernig, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assaysG Zernig, T Burke, J W Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Butorphanol: characterization of agonist and antagonist effects in rhesus monkeysE R Butelman, G Winger, G Zernig, et al.
Arzneimittel-Forschung|January 1, 1985
Calcium channels and calcium channel drugs: recent biochemical and biophysical findingsH Glossmann, D R Ferry, A Goll, et al.
Neuroscience Applied|July 14, 2025
Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysisF Amann, M Kochtyrew, G Zernig, et al.
The American Journal of Cardiology|November 7, 1989
Hydrophobic calcium channel ligands: methodical problems and their solutionI Graziadei, G Zernig, A Grassegger, et al.
Pharmacology|March 28, 2003
Intravenous drug injection habits: drug users' self-reports versus researchers' perceptionG Zernig, S Giacomuzzi, Y Riemer, et al.
Molecular Pharmacology|September 1, 1990
Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channelG Zernig, I Graziadei, T Moshammer, et al.
Pageof 6